CircNDST1 promotes papillary thyroid cancer progression via its interaction with CSNK2A1 to activate the PI3K–Akt pathway and epithelial–mesenchymal transition

[1]  Shao-jian Lin,et al.  Circular RNA_0057209 Acts as ceRNA to Inhibit Thyroid Cancer Progression by Promoting the STK4-Mediated Hippo Pathway via Sponging MicroRNA-183 , 2022, Oxidative medicine and cellular longevity.

[2]  Wanqing Chen,et al.  Cancer statistics in China and United States, 2022: profiles, trends, and determinants , 2022, Chinese medical journal.

[3]  U. Megwalu,et al.  Thyroid Cancer Incidence and Mortality Trends in the United States: 2000 - 2018. , 2022, Thyroid : official journal of the American Thyroid Association.

[4]  Chao Huang,et al.  Circ0008399 Interaction with WTAP Promotes Assembly and Activity of the m6A Methyltransferase Complex and Promotes Cisplatin Resistance in Bladder Cancer , 2021, Cancer Research.

[5]  M. Luu,et al.  Predictive impact of metastatic lymph node burden on distant metastasis across papillary thyroid cancer variants. , 2021, Thyroid : official journal of the American Thyroid Association.

[6]  Hao Xu,et al.  CSNK2A1‐mediated phosphorylation of HMGA2 modulates cisplatin resistance in cervical cancer , 2021, FEBS open bio.

[7]  A. F. Neuwald,et al.  Identifying intracellular signaling modules and exploring pathways associated with breast cancer recurrence , 2021, Scientific reports.

[8]  Y. Bae,et al.  CK2 Down-Regulation Increases the Expression of Senescence-Associated Secretory Phenotype Factors through NF-κB Activation , 2021, International journal of molecular sciences.

[9]  E. Port,et al.  Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease , 2020, Nature Communications.

[10]  C. Mitchell,et al.  PTEN and Other PtdIns(3,4,5)P3 Lipid Phosphatases in Breast Cancer , 2020, International journal of molecular sciences.

[11]  Guoxin Zhang,et al.  circCUL2 regulates gastric cancer malignant transformation and cisplatin resistance by modulating autophagy activation via miR-142-3p/ROCK2 , 2020, Molecular cancer.

[12]  A. Zaravinos,et al.  Signatures of co-deregulated genes and their transcriptional regulators in colorectal cancer , 2020, npj Systems Biology and Applications.

[13]  J. Tapia,et al.  Protein Kinase CK2 in Cancer Energetics , 2020, Frontiers in Oncology.

[14]  Dan Sun,et al.  Circular RNAs in Cancer: Biogenesis, Function, and Clinical Significance. , 2020, Trends in cancer.

[15]  Zhenjie Wu,et al.  CircRNA cRAPGEF5 inhibits the growth and metastasis of renal cell carcinoma via the miR-27a-3p/TXNIP pathway. , 2020, Cancer letters.

[16]  A. Alzahrani.  PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside. , 2019, Seminars in cancer biology.

[17]  P. Jänne,et al.  An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer , 2019, EBioMedicine.

[18]  Jørgen Kjems,et al.  The biogenesis, biology and characterization of circular RNAs , 2019, Nature Reviews Genetics.

[19]  K. L. La Perle,et al.  MAPK- and AKT-activated thyroid cancers are sensitive to group I PAK inhibition. , 2019, Endocrine-related cancer.

[20]  Qi Zhou,et al.  A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling , 2019, Molecular Cancer.

[21]  C. Blanpain,et al.  EMT Transition States during Tumor Progression and Metastasis. , 2019, Trends in cell biology.

[22]  A. F. Castro,et al.  CK2 inhibition with silmitasertib promotes methuosis-like cell death associated to catastrophic massive vacuolization of colorectal cancer cells , 2019, Cell Death & Disease.

[23]  C. Gong,et al.  Circular RNA hsa_circ_001783 regulates breast cancer progression via sponging miR-200c-3p , 2019, Cell Death & Disease.

[24]  C. Eng,et al.  PTEN-opathies: from biological insights to evidence-based precision medicine. , 2019, The Journal of clinical investigation.

[25]  G. Buitrago,et al.  Intermediate-Risk Papillary Thyroid Cancer: Risk Factors for Early Recurrence in Patients with Excellent Response to Initial Therapy. , 2018, Thyroid : official journal of the American Thyroid Association.

[26]  V. Mittal.  Epithelial Mesenchymal Transition in Tumor Metastasis. , 2018, Annual review of pathology.

[27]  P. Santisteban,et al.  MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN , 2018, Oncogene.

[28]  K. Jang,et al.  CK2α/CSNK2A1 Phosphorylates SIRT6 and Is Involved in the Progression of Breast Carcinoma and Predicts Shorter Survival of Diagnosed Patients. , 2016, The American journal of pathology.

[29]  David R. Jones,et al.  CK2α' Drives Lung Cancer Metastasis by Targeting BRMS1 Nuclear Export and Degradation. , 2016, Cancer research.

[30]  G. Unger,et al.  CK2: A key player in cancer biology , 2009 .

[31]  G. Unger,et al.  Protein Kinase CK2 in Health and Disease , 2009, Cellular and Molecular Life Sciences.

[32]  L. Pinna,et al.  Protein kinase CK2 phosphorylates and upregulates Akt/PKB , 2005, Cell Death and Differentiation.